<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Whittle EF</submitter><funding>NICHD NIH HHS</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>100332</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9905285</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(2)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>This study aimed to establish the genetic cause of a novel autosomal recessive neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities.&lt;h4>Methods&lt;/h4>We performed a detailed clinical characterization of 4 unrelated individuals from consanguineous families with a neurodevelopmental disorder. We used exome sequencing or targeted-exome sequencing, cosegregation, in silico protein modeling, and functional analyses of variants in HEK293 cells and Drosophila melanogaster, as well as in proband-derived fibroblast cells.&lt;h4>Results&lt;/h4>In the 4 individuals, we identified 3 novel homozygous variants in oxoglutarate dehydrogenase (OGDH) (NM_002541.3), which encodes a subunit of the tricarboxylic acid cycle enzyme α-keto</pubmed_abstract><journal>Genetics in medicine : official journal of the American College of Medical Genetics</journal><pubmed_title>Biallelic variants in OGDH encoding oxoglutarate dehydrogenase lead to a neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities.</pubmed_title><pmcid>PMC9905285</pmcid><funding_grant_id>MR/S01165X/1</funding_grant_id><funding_grant_id>P20 GM103636</funding_grant_id><funding_grant_id>G0601943</funding_grant_id><funding_grant_id>MR/N013638/1</funding_grant_id><funding_grant_id>NIHR205088</funding_grant_id><funding_grant_id>R01 NS121298</funding_grant_id><funding_grant_id>MR/S005021/1</funding_grant_id><funding_grant_id>P50 HD105354</funding_grant_id><funding_grant_id>R01 GM142143</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Houlden H</pubmed_authors><pubmed_authors>Ignatius E</pubmed_authors><pubmed_authors>Buhas D</pubmed_authors><pubmed_authors>Pittman AM</pubmed_authors><pubmed_authors>Karimiani EG</pubmed_authors><pubmed_authors>Badv RS</pubmed_authors><pubmed_authors>Chilian M</pubmed_authors><pubmed_authors>Kose M</pubmed_authors><pubmed_authors>Toosi MB</pubmed_authors><pubmed_authors>Ganetzky RD</pubmed_authors><pubmed_authors>Maroofian R</pubmed_authors><pubmed_authors>Whittle EF</pubmed_authors><pubmed_authors>Torbati PN</pubmed_authors><pubmed_authors>Progri H</pubmed_authors><pubmed_authors>Rahman S</pubmed_authors><pubmed_authors>Carroll CJ</pubmed_authors><pubmed_authors>Jamshidi Y</pubmed_authors><pubmed_authors>Shelihan I</pubmed_authors><pubmed_authors>Elloumi HZ</pubmed_authors><pubmed_authors>Yoon WH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biallelic variants in OGDH encoding oxoglutarate dehydrogenase lead to a neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities.</name><description>&lt;h4>Purpose&lt;/h4>This study aimed to establish the genetic cause of a novel autosomal recessive neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities.&lt;h4>Methods&lt;/h4>We performed a detailed clinical characterization of 4 unrelated individuals from consanguineous families with a neurodevelopmental disorder. We used exome sequencing or targeted-exome sequencing, cosegregation, in silico protein modeling, and functional analyses of variants in HEK293 cells and Drosophila melanogaster, as well as in proband-derived fibroblast cells.&lt;h4>Results&lt;/h4>In the 4 individuals, we identified 3 novel homozygous variants in oxoglutarate dehydrogenase (OGDH) (NM_002541.3), which encodes a subunit of the tricarboxylic acid cycle enzyme α-keto</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-05-28T11:51:29.441Z</modification><creation>2025-04-07T03:19:43.419Z</creation></dates><accession>S-EPMC9905285</accession><cross_references><pubmed>36520152</pubmed><doi>10.1016/j.gim.2022.11.001</doi></cross_references></HashMap>